| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |